Katerina A. Turner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Katerina A. Turner has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Gonzales
Harvard Medical School
1 shared publication - Barry L. Wanner
Harvard Medical School
1 shared publication - Cameron L. Gardner
JURA Bio
1 shared publication - Christopher Gregg
Department of Neurobiology, University of Utah, Salt Lake City, UT, USA
1 shared publication - Conor K. Camplisson
Department of Genome Sciences, University of Washington
1 shared publication - David K. Barclay
Harvard Medical School
1 shared publication
Latest Publications
- Open Access
Assembly of Radically Recoded E. coli Genome Segments
The large potential of radically recoded organisms (RROs) in medicine and industry depends on improved technologies for efficient assembly and testing of recoded genomes for biosafety and functionality. Here we describe a next generation platform for conjugative assembly genome engineering, termed CAGE 2.0, that enables the scarless integration of large synthetically recoded E. coli segments at isogenic and adjacent genomic loci. A stable tdk dual selective marker is employed to facilitate cyclical assembly and removal of attachment sites used for targeted segment delivery by sitespecific recombination. Bypassing the need for vector transformation harnesses the multi Mb capacity of CAGE, while minimizing artifacts associated with RecA-mediated homologous recombination. Our method expands the genome engineering toolkit for radical modification across many organisms and recombinase-mediated cassette exchange (RMCE).
Open AccessAssembly of Radically Recoded E. coli Genome Segments
The large potential of radically recoded organisms (RROs) in medicine and industry depends on improved technologies for efficient assembly and testing of recoded genomes for biosafety and functionality. Here we describe a next generation platform for conjugative assembly genome engineering, termed CAGE 2.0, that enables the scarless integration of large synthetically recoded E. coli segments at isogenic and adjacent genomic loci. A stable tdk dual selective marker is employed to facilitate cyclical assembly and removal of attachment sites used for targeted segment delivery by sitespecific recombination. Bypassing the need for vector transformation harnesses the multi Mb capacity of CAGE, while minimizing artifacts associated with RecA-mediated homologous recombination. Our method expands the genome engineering toolkit for radical modification across many organisms and recombinase-mediated cassette exchange (RMCE).